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Abstract
Background: The In the Trenches series of cutting-edge knowledge sharing events on impact for front-line experts
and practitioners provides an engagement platform for diverse stakeholders across government, research funding
organizations, industry, and academia to share emerging knowledge and practical experiences. The second event of
the series In the Trenches: Implementation to Impact International Summit was held in Banff, Alberta, Canada, on June
7–8, 2019. The overarching vision for the Summit was to create an engagement platform for addressing key
challenges and finding practical solutions to move from implementation (i.e. putting findings into effect) to impact
(i.e. creating benefits to society and the economy).
Processes and proceedings: The Summit used diverse approaches to facilitate active engagement and knowledge
sharing between 80 delegates across sectors and jurisdictions. Summit sessions mostly consisted of short talks and
moderated panels grouped into eight thematic sessions. Each presentation included a summary of Key Messages,
along with a summary of the Actionable Insights which concluded each session. The presentations and discussions
are analysed, synthesized and described in this proceedings paper using a systems approach. This demonstrates
how the Summit focused on each of the necessary functions (and associated components) that should be
undertaken, and combined, for effective research and innovation: stewardship and governance, securing finance,
creating capacity, and producing and using research. The approach also identifies relevant challenges.
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: kathryn.graham@albertainnovates.ca
From In the Trenches: Implementation to Impact International Summit Banff,
Alberta, Canada. 7-8 June 2019
3Alberta Innovates, 1500, 10104-103 Avenue NW, Edmonton, AB T5J 0H8,
Canada
Full list of author information is available at the end of the article
BMC ProceedingsHanney et al. BMC Proceedings 2020, 14(Suppl 6):10https://doi.org/10.1186/s12919-020-00189-x
(Continued from previous page)
Conclusions: There is increased interest globally in the benefits that can accrue from adopting a systems approach
to research and innovation. Various organizations in Canada and internationally have made considerable progress
on Implementation to Impact, often as a result of well-planned initiatives. The Summit highlights the value of 1)
collaboration between researchers and potential users, and 2) the adoption by funders of approaches involving an
increasing range of responsibilities and activities. The Summit website (https://inthetrenchessummit.com/) will be
periodically updated with new resources and information about future In the Trenches events.
Keywords: Research impact assessment, Implementation science, Innovation, Research, Systems approach,
Engagement, Alberta Innovates
Background
Research and innovation (R&I) is the engine of sustain-
able social progress and economic growth. R&I is cre-
ated across disparate sectors and communities of
practice, therefore, experts and practitioners implement-
ing research and assessing its impact at the front-line re-
quire an engagement platform. The In the Trenches
series of cutting-edge knowledge sharing events on im-
pact for front-line experts and practitioners provides an
engagement platform for diverse stakeholders across
government, research funding organizations, industry,
and academia to share emerging knowledge and prac-
tical experiences.
Building on the success of the International School for
Research Impact Assessment (ISRIA) [1], the series was
launched with the inaugural In the Trenches: Research
Translation for Health Impact International Symposium
held at the University of Oxford, United Kingdom, on
November 16, 2018 [2–4]. Supported by the National In-
stitute for Health Research (NIHR) Oxford Biomedical
Research Centre [5], it had a focus on assessing and
optimizing the translational value of health R&I using
co-creation approaches, whereby researchers and practi-
tioners engage with multiple stakeholders to devise
products and services that increase their value for
everyone.
The second event of the series In the Trenches:
Implementation to Impact International Summit was
held in Banff, Alberta, Canada, on June 7–8, 2019.
The Summit was organized by Alberta Innovates (AI)
– Alberta’s research and innovation corporation –
and co-hosted with the University of Oxford. As part
of its mandate, AI provides advice and connections to
stimulate and grow R&I in Alberta with a view to
contributing to a diversified economy, cleaner and
sustainable environment and healthier communities
[6]. The Summit is an example of AI’s convener role
bringing together communities of practice that have
the potential to contribute to solving the grand chal-
lenges in these priority areas and address the valley
of death in implementing and scaling innovations for
achieving impact. The challenge of “bridging the val-
leys of death” with a greater understanding of the
“time lags” between critical points across the research
and innovation pipeline is a topic of growing interest
by those interested in maximizing the rate of returns
from R&I investments [7]. To address societal prob-
lems, a system approach is needed, one that aligns
strategic priorities with stakeholder interests and
values. To do this, AI recognizes the need to be re-
sponsive and engage stakeholders across the R&I life-
cycle from the generation of solutions to involving
end-users in adopting and scaling innovations to
achieve intended impacts.
The Summit had a focus on scale and spread of
R&I in the local Albertan, national Canadian, and
relevant international contexts. The overarching vision
for the Summit was to create an engagement platform
to address key challenges and find practical solutions
to implementing and scaling innovations for achieving
impact. The aspiration is to accelerate and optimize
the impact of R&I by having implementation experts
share their knowledge and practices with impact ex-
perts and vice versa. The aims of the Summit were:
 Advance the science of implementation and impact
by engaging in interdisciplinary dialogue.
 Share leading approaches and frameworks for
implementation and impact, with a particular focus on
scale and spread of R&I in local and international
contexts.
 Engage the implementation and impact
communities in a lively dialogue regarding common
challenges and ways of working together to move
implementation to impact in complex environments.
 Facilitate networking opportunities between impact
and implementation communities, across sectors
and jurisdictions.
Looking to the future and in the words of Laura
Kilcrease (CEO, Alberta Innovates) “what we need to
do here in Canada, and Alberta specifically is expand
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our views beyond our borders… we have to get our
innovation into a product, get the product into a tan-
gible market, and then make the linkages and connec-




The Summit brought together 80 leading R&I professionals,
including program managers, evaluators, knowledge transla-
tion practitioners, research impact assessment and imple-
mentation scientists, entrepreneurs, policy makers, and
patient representatives. Summit delegates represented orga-
nizations in healthcare (39%), R&I funders (18%), academia
(17%), not-for-profits, industry and the business community
(12%), government and media (4% each respectively) and
others (6%). Among the delegates in attendance, 57% worked
within the health sector. While a 74% majority of delegates
were from Alberta and other Canadian provinces (8%), 19%
of delegates were international – from Australia, Austria,
Denmark, Netherlands, Spain, the United Kingdom (UK),
and the United States of America (USA).
Program development
The Summit Program (see Additional File 1) was devel-
oped by the International Organizing Committee and
co-directed by Drs. Kathryn Graham (Alberta Innovates)
and Pavel Ovseiko (University of Oxford). In response to
feedback on the initial idea for the Summit conceived by
Graham, and newly emerging ideas from stakeholders
and presenters, extensive iterations of the event schedule
and line-up of presenters were made. The presenters de-
termined the format and refined the content of every
session via teleconference calls and email communica-
tion. The planning, organization, stakeholder engage-
ment, promotion and communication, and post-Summit
evaluation were undertaken by the AI team with input
from the Alberta Innovates Advisory Committee. An
additional file lists the Members of the International Or-
ganizing Committee and the Alberta Innovates Advisory
Committee (see Additional file 2).
Promotion and communication
The Summit was promoted to potential delegates in
Canada and internationally via email, social media, and
the AI website. The following groups were specifically
engaged to promote local, national, and international
participation and expertise in implementation and
impact:
International R&I funding organizations
The Agency for Health Quality and Assessment of Cata-
lonia (AQuAS), the NIHR in England, the Netherlands
Organization for Health Research and Development
(ZonMw), and the Commonwealth Scientific and Indus-
trial Research Organization (CSIRO) in Australia were
considered key international stakeholders given their
work advancing research impact and implementation.
Canadian Institutes of Health Research (CIHR)
CIHR is Canada’s national funding body for health re-
search and is committed to assessing the impact of its
investments.
National Alliance of Provincial Health Research
Organizations (NAPHRO)
Members of this Canadian organization were considered
for their expertise in health impact and impact assess-
ment, R&I system knowledge, and extensive network of
stakeholders.
Alberta Health Services (AHS)
Alberta delivers health services through AHS, the prov-
ince’s single, integrated health system. Participation of
AHS implementation practitioners and scholars would
enhance dialogue and promote collaborations to address
local challenges.
Alberta Strategy for Patient-Oriented Research SUPPORT
Unit (AbSPORU)
Patient-oriented research is a potential mechanism for
advancing implementation and impact of R&I. Engaging
AbSPORU and its network would provide insight into
challenges and potential solutions to scaling health re-
search innovations for impact at local and national
levels.
Government of Alberta ministries
The Ministry of Economic Development and Trade (now
Ministry of Economic Development, Trade, and Tourism)
and the Ministry of Health were invited to participate due
to their strategic investments in provincial R&I and gov-
ernance across sectors (e.g. Health, Energy).
Government of Canada ministries
The Ministry of Science (now Ministry of Innovation,
Science and Industry) and the Ministry of Small Busi-
ness and Export Promotion (now Ministry of Small Busi-
ness, Export Promotion and International Trade) were
engaged given their role in R&I policy and governance
in industry at the federal level.
Academic institutions
Alberta universities were considered a key stakeholder
given their role within the local R&I ecosystem and in
advancing implementation science.
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Cross-sector industries
In addition to the health sector, stakeholders from en-
ergy and environment (e.g. Emissions Reduction
Alberta), Agriculture (e.g. Ministry of Agriculture and
Forestry in Alberta), and technology (e.g. InnoTech)
were engaged to provide broad perspectives on imple-
mentation and impact.
Business and innovation community
The Summit was promoted as part of a wider program
of INVENTURE$ connect events occurring concurrently
in Alberta. These events were organised by AI to bring
venture capitalists, angel investors, startups, entrepre-
neurs, service providers and thought leaders together to
discover and share the latest in innovation, research,
capital access and deal-making. This extended the po-
tential reach to national and international delegates with
expertise in the scale of innovation in business.
Seven months prior to the Summit, a save-the-date
flyer was circulated to the specific groups. Members of
the International Organizing Committee promoted the
Summit via personal engagement and presentations at
relevant meetings and conferences. For 3 months leading
up to the event, information about the Summit and the
subsequent updates were posted on Twitter using a ded-
icated hashtag #implementation2impact.
Summit format and peer-to-peer engagement
The Summit had a 1.5-day format commonly used for
in-person scientific meetings [8]. Summit sessions
mostly consisted of short presentations and moderated
panels grouped into eight themes (see Additional File 1).
Each presentation included a summary of Key Messages,
and every session concluded with a summary of Action-
able Insights. The opening and closing keynote addresses
by Pavel Ovseiko and Stephen Hanney helped to frame
the event themes in context and tie concepts discussed
at the Summit to theory and or frameworks used in im-
plementation science and impact assessment. The key-
note speakers also contributed to the Summit’s synthesis
of Key Messages and associated Actionable Insights.
An overarching goal of the Summit was to facilitate
meaningful and authentic engagement among delegates
(presenters included) to promote networking, formal
and informal learning, and collaboration. To achieve this
aim, the engagement strategy used during the Summit
focused on creating a collegial and relaxed environment
to encourage open and ‘out of the box’ exchange using
various and frequent touch points both inside and out-
side of formal program sessions. While many of the fea-
tures of the Summit may be found at other conferences,
the extent of the range of engagement approaches used
is noteworthy:
Seating
The Summit venue was arranged “cabaret” style, with
seating comprised of round tables with an open end fa-
cing the stage. This arrangement encouraged delegates
to interact and exchange opinions during Summit
sessions.
Delegate packs
Included in the delegate’s event package was a contact
list of those who consented to share their information,
and a Speaker Summary sheet outlining the biographies
and experience of those speaking at the event: delegate
feedback suggested these resources were particularly
valuable in facilitating connections both during the event
and after. Among the 80 delegates in attendance, 31
(39%) participated as Keynote speakers, session pre-
senters and panellists. An updated contact list was dis-
tributed post-Summit to help delegates maintain newly
established connections and encourage future contacts
and collaborations.
Social connection activities
Each day opened with an icebreaker activity to foster
connections between delegates and closed with an even-
ing social event to provide further opportunity for net-
working. For example, the first day opened with an
activity that had delegates find a fellow delegate they had
not previously met, then tell each other where they were
from and the most interesting thing about that place.
Social media
Twitter was used both for traditional online dissemin-
ation and engagement as well as to facilitate personal
connections through a contest. The “My New Best
Friend Forever (BFF)” contest had delegates take selfies
with a delegate(s) they just met at the Summit and post
to Twitter with the hashtags #implementation2impact
and #newBFF.
Dialogue with presenters
Ensuring contact between speakers and other delegates
was an explicit intention of the organizers and was ad-
dressed not only with general networking sessions, but
also with, “Dialogues with Presenters” opportunities.
Here session speakers made themselves available for fur-
ther engagement among those interested: these Dialogue
moments provided interested delegates with opportun-
ities for critical discussion and reflection with presenters.
In addition to providing opportunity for dialogue, this
activity was designed to cultivate a collegial and collab-
orative environment that reinforced peer-to-peer en-
gagement (i.e. presenters were considered peers).
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World Café sessions
To achieve the Summit’s aim of engaging implementa-
tion and impact communities to address complex trans-
lational challenges, organizers felt it was essential to
provide a small group activity to facilitate active partici-
pation of all delegates. Therefore, in addition to the pre-
sentations and panel discussions, the concurrent small
group sessions in the World Café provided an opportun-
ity to gather delegate input about practical actions that
could be taken to advance implementation and impact
efforts and barriers to progress in these areas. Concur-
rent sessions enabled frank dialogue and reinforced op-
portunities to forge connections between delegates.
Exhibition table
The Exhibition Table was a designated area that rein-
forced engagement and learning through the display of
knowledge and promotional products made available to
delegates. Delegates could broaden their knowledge of
the work being done by the organizations and groups
represented at the Summit by visiting the exhibition
stand which included research articles and print copies
of select reports and guidelines mentioned at the event,
as well as other items including badges and other pro-
motional and engagement materials.
Summit website
A Summit website (https://inthetrenchessummit.com/)
was launched 2 months prior to the event. The website
initially contained information about the Summit date
and location, schedule, speakers, and how to register. A
Resources page was added to the website: there seminal
pre-reading items identified by confirmed speakers were
posted for those interested in learning more about the
Summit’s topics and themes in advance of the event.
After the Summit, the website’s Resource page was up-
dated to facilitate further post-event engagement and
learning. The Resources page contains 25 Summit pre-
sentations, Open Access articles, and other relevant ma-
terials selected by the speakers. The website will be
periodically updated with new resources and information
about future In the Trenches events.
Summit evaluation
An online post-event evaluation of the Summit was
conducted. The purpose of the evaluation was to as-
sess delegate experience and achievement of objec-
tives and was used gather information to inform
plans for the In the Trenches series. In total, 23 of 77
delegates invited to participate responded to the sur-
vey (30% response rate).
Overall, nearly all respondents (94%) were satisfied
with the Summit and most (79%) would recommend In
The Trenches events to others. The achievement of
objectives was also rated favorably, with scores for the
seven objectives ranging between 86 and 100% (Fig. 1).
Respondents reported that opportunities to meet new
people and learn about the application of implementa-
tion and impact considerations in scale and spread pro-
jects and initiatives from different perspectives was the
most useful aspect of the event. Nevertheless, several re-
spondents identified the need for more practical infor-
mation on implementing some of the ideas presented.
At approximately 7-weeks following the event, 48% of
those surveyed had subsequently engaged or followed up
with another delegate for the primary purpose of on-
going knowledge exchange and sharing. Some reported
additional reasons for engagement, as this respondent’s
quote illustrates: “Following up on ideas and shared ex-
periences; discussing possibilities for future collaboration;
making friends.”
Analytics from the Summit’s social media channels –
the event website and twitter hashtag – were also exam-
ined to understand the reach and engagement achieved
through these mechanisms. In total, the website received
3178 page views from 1069 new or unique visitors; the
most common sources of website traffic were through
visitors directed to the site (74%), referral from others
(16%), social media (4%) and organic searches (3%).
Additionally, the event hashtag (#Implmentation2Im-
pact) was tweeted and retweeted more than 200 times
with those messages receiving 343 likes.
Systems approach
In his closing remarks summarising the Summit, Hanney
noted how the presentations from some organisations
clearly suggested they were adopting a systems approach
as they described their various actions to boost progress
in aspects of the R&I journey. Additionally, the first
session of the World Café (Session 6A) was explicitly de-
scribed as involving a dialogue about “a ‘systems ap-
proach’ to innovation achieving impact.” Furthermore,
the focus throughout the Summit on engagement and
interactions between different stakeholders, and the in-
creasing roles for research funders, facilitates – in some
ways almost demands – the adoption of a systems ap-
proach in the analysis of the Summit’s proceedings.
Therefore, post-Summit discussions within the team of
authors of this paper, and some others involved with the
Summit (see Acknowledgements), led to agreement on
the potential value of incorporating a systems approach
into the current proceedings because it:
a) provides a structure for systematically analysing
what was said at the Summit about Implementation
to Impact in ways that do justice to the richness of
the discussions;
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b) highlights and draws on how some funders are
already making progress in applying aspects of a
systems-type approach, which is also helping to
generate, and in turn being strengthened by, an im-
pact culture and enhanced sustainability;
c) facilitates a demonstration of the implementation
and impact benefits associated with embedding a
health R&I system into the healthcare system;
d) illustrates potential ways of addressing the
challenges of Implementation to Impact and
tensions that were identified at the Summit; and
e) identifies ways in which progress could be made
across the board in promoting Implementation to
Impact. Here, ways can be identified also to boost
key themes that were common across various
presentations.
Fig. 1 In The Trenches Summit Infographic of Delegate Evaluation
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Therefore, the proceedings will be organized around
points a) – e) above and presented in three sections.
These three sections are briefly introduced here and will
then be presented in full in Proceedings Sections 1-3.
In the first section, analysing the presented material
according to the eight components of a (health) research
system, the components of a health research system
framework will be used to organize an interpretive ac-
count and analysis of the diverse Summit presentations.
The most appropriate starting point is deemed to be the
health research systems framework developed for the
World Health Organization (WHO) [9]. This health re-
search systems framework has four functions, each with
one or more components. The functions cover the full
range of activities necessary if adopting a systems ap-
proach going from stewardship and governance, through
securing finance and building capacity, to producing and
using research. Informed by this, but amending it for
our purposes, the eight operational components to be
used here are listed below:
1. Define and Articulate Vision for a (Health) R&I
System
2. Identify Appropriate (Health) R&I Priorities
3. Set and Monitor Ethical Standards for (Health) R&I
and Research Partnerships
4. Monitor and Evaluate the (Health) R&I System
5. Secure Funding for (Health) Research and R&I
System Building
6. Build, Strengthen and Sustain the Human and
Physical Capacity to Conduct, Absorb and Utilize
(Health) Research
7. Produce Scientifically Valid (Health) Research
Outputs
8. Communicate and Promote Research to Inform
(Health) Policy, Practices and Public Opinion and
to Develop Tools (e.g. Drugs and Devices) to
Improve Health, Society and the Economy.
Aspects of all the components were mentioned at
the Summit, even though in some cases they did not
form the basis of a specific session. Furthermore,
while this framework was explicitly developed for a
national system, and for health research, the presenta-
tions by contributors from other fields, including
from organizations that funded research in multiple
fields, can also be described using the above list of
components. More recent analysis for the WHO sug-
gests a crucial factor for a successful research system
is ensuring as comprehensive and coherent coverage
of the various components as possible [10]. A study
conducted to inform public involvement in health re-
search in Ontario, Canada, recently used the WHO
health research system framework to analyse and
learn lessons from systems where such public involve-
ment was particularly well developed. The two case
studies therefore focused on Alberta and England
[11].
In the above list of components the original WHO
framework has been specifically adapted to help analyse/
promote Implementation to Impact. For example, the fi-
nancing component in this context also relates to secur-
ing resources for conducting the diverse activities
necessary to organize a systems approach to facilitating
Implementation to Impact. Usually, each national re-
search system has its own diverse pattern of funders,
therefore, the framework should be seen more as a way
of organizing thinking and items to consider, rather than
as providing a precise blueprint or template for con-
struction of an R&I system. All the presentations from a
single session are described together in Additional file 3,
but some presentations – or specific points from them –
will be discussed separately from the rest of their session
where that assists coverage of the components and facili-
tates comprehensive coverage of the scope of the Sum-
mit. Furthermore, various presentations, or the
discussions they informed, will be drawn upon in the ac-
count of more than one component.
In Section Two, Discussion of emerging themes and
challenges, the various presentations and discussions
(outlined in Additional file 3) will be drawn upon to ana-
lyse each of points b), c) and d) above, as outlined here
in the following three bullet points:
 In relation to the development of a systems
approach, many of the presentations illustrated that
certain research systems, and/or major funders, are
already making progress along these lines. These
developments will be analysed, by considering how
adoption of a comprehensive and coherent systems
approach means the various specific elements will be
mutually reinforcing and help to generate, and in
turn be strengthened by, an impact culture and
enhanced sustainability. These organizations include
three major funders of health research mentioned
above from Spain, England and the Netherlands
respectively: AQuAS, NIHR, and ZonMw.
Additionally, while AI covers various fields, much of
the focus at the Summit was on its role in the health
field. CSIRO in Australia also funds research in
many fields.
 Some presentations, especially from AI, illustrated
how research systems are being embedded into the
relevant healthcare system. Evidence about the
feasibility and benefits of this approach will be
analysed.
 Despite accounts of progress in scaling and
spreading R&I results more broadly, some Summit
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presentations and discussions provided examples of
challenges and tensions facing Implementation to
Impact, and the role of a systems approach in
facilitating ways to address them. Such challenges
and tensions include, for example:
– how to reduce the time often taken to achieve
implementation and impact and yet allow time to
build up the appropriate structures, capacity and
learning;
– how to address the inevitable resistance to
change from both producers and potential users
of research;
– the many and genuine difficulties facing attempts
to increase coproduction in research;
– the need to avoid the previously reported high
rate of research waste [12] and to provide value;
and
– the importance of ensuring the robustness of the
research before attempting to achieve impact by
implementing the findings, which also has
implications for the balance between use of local
and global research.
Section three, Lessons and further work, will describe
ideas proposed at the Summit for progressing Implemen-
tation to Impact, through encouraging a systems ap-
proach to incorporate the various components. This
section also explores the possibility of developing a new
framework to build upon and advance this work. Add-
itionally, some practical guides relevant to points made
in the Summit will be listed, even in some cases when
they were not specifically referenced in the presenta-
tions. Finally, the possibility of taking these ideas for-
ward in future events will be explored.
Section one: analysing the presented material
according to the eight components of a (health)
research system
Component one: define and articulate vision for a (health)
R&I system
In the context of Implementation to Impact, it is import-
ant that the research system, or funder, should not only
articulate a vision, but also that the vision should
emphasize the importance of the research making a soci-
etal impact. Early examples of text that today might be
seen as vision and/or mission statements were not ne-
cessarily called that at the time. Peter Riddles (CSIRO)
(Session 2A) highlighted that in Australia the original
Science and Industry Research Act 1949 establishing the
CSIRO had referred to the utilisation of research. Ac-
cording to the Act, CSIRO’s functions were as follows
[13]:
(a) to carry out scientific research for any of the fol-
lowing purposes:
(i) assisting Australian industry;
(ii) furthering the interests of the Australian
community;
(iii) contributing to the achievement of Australian na-
tional objectives or the performance of the national and
international responsibilities of the Commonwealth;
(iv) any other purpose determined by the Minister;
(b) to encourage or facilitate the application or
utilization of the results of such research;
(ba) to encourage or facilitate the application or util-
isation of the results of any other scientific research;
In the Key Messages from his presentation, Riddles de-
scribed various ways in which business innovation had
evolved in Australia, and that agencies such as CSIRO
had a role in this (Session 2Aii – see in Additional file
3).
In the World Café discussion session that specifically
considered “a ‘systems’ approach to innovation achieving
impact” it was suggested that a “shared vision” was one
of the innovation enablers (6Ai). The importance of
nurturing key values within a research system was
highlighted in contributions such as that from Adam
Kamenetzky (Actionable Insights, Session 5E). He
claimed, “equality, diversity and inclusion are fundamen-
tal aspects that ought to be considered at all levels of the
research and innovation ‘ecosystem’”. Vision and mission
statements provide opportunities for the values of the
R&I system to be promoted.
Component two: identify appropriate (health) R&I
priorities
When the concern is Implementation to Impact, it is
even more important than usual that the priority setting
is appropriate to the needs of the intended users. The in-
volvement of relevant stakeholders was a major theme
throughout the Summit.
Some of the presentations/sessions focused on the en-
gagement of a wide range of stakeholders in identifying
topics, or setting the agenda, for the research that would
meet the needs of the relevant system. Others, especially
session 4, focused specifically on the importance of en-
gaging the patients and public.
Jean Miller, a patient representative in Alberta and
member of Patient and Community Engagement Re-
search (PaCER), emphasized the importance of meaning-
ful participation of patients in R&I in order to achieve
implementation and impact (Session 4A). Her top Key
Message was: “First find out what’s important to patients
and study that”’ (4Ai). In discussion, she also described
how experienced patient representatives should be part
of the team providing training to new patient represen-
tatives in order to enable them to fully participate.
Lauren Gerlach from AcademyHealth in the USA de-
scribed various ways of facilitating and promoting patient
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engagement throughout the research lifecycle (Session 4C).
In her presentation, she also illustrated a practical tool de-
veloped by the Patient-Centered Outcomes Research Insti-
tute (PCORI) in the USA that provides information on the
engagement of patients and other stakeholders in research.
Their Engagement in Health Research Literature Explorer
database [14] allows the body of relevant literature to be
searched by items such as types of stakeholder, and phases
of research engagement going from identifying research
questions to dissemination and uptake of results.
Various important practical points about how to sup-
port patient engagement were also made in the discussion
in session 4. Examples include offering support for pa-
tients to engage in research by providing, for example,
lunch and childcare support. Mechanisms to ensure pa-
tient involvement were also discussed, for example, by
making it a condition of funding. (Guidelines covering
much of this are also available on the website of IN-
VOLVE, the part of the NIHR in England that promotes
public and patient engagement in health research [15]).
In one of his Actionable Insights from session 4, Tim
Murphy identified patients as the primary audience for
the results and efforts related to R&I in health, and that
“Partnership improves the quality and relevance of re-
searchers’ work and it also empowers the patient part-
ners” (4D). Therefore, those building R&I systems
should “Design and implement research and innovation
programs and initiatives with this central partnership
concept in mind” (4D). A similar concept was identified
in themes from the World Café discussion, Addressing
Sustainability in Real-World Applications (Session 6B):
“Sustainability research needs the patient lens as a
design-level lens” (6Bii).
While Component Two of the (health) research sys-
tem very much focuses on research priority-setting, in
session 4, and other instances, Summit speakers also de-
scribed how stakeholder engagement should continue
after the topic identification at meaningful points along
the R&I continuum. Therefore, the important aspects of
stakeholder engagement are applicable to other compo-
nents of R&I systems, as illustrated in the Key Messages
raised by organizations including the Ontario Brain
Institute (OBI) (Session 4B). Some Summit presentations
focused on the role of stakeholder engagement in devel-
oping impact assessment strategies – these are mostly
considered in Component Four on monitoring and
evaluation (M&E).
The overlaps are particularly complex in the comprehen-
sive Health Research and Innovation Assessment System
(SARIS) being developed by AQuAS in Catalonia and de-
scribed by Núria Radó-Trilla in session 3B. In the context
of ongoing engagement with stakeholders to develop the
system of assessment, SARIS also encourages stakeholder
engagement in research “to promote impact”. In her
presentation, Radó-Trilla gave the example of a programme
of nursing research where the engagement was with pa-
tients, in particular, to understand research needs.
Similarly, in describing the comprehensive approach to-
wards implementation and impact taken by CSIRO, Tom
Keenan declared “Researchers must engage effectively with
end users and other key stakeholders at appropriate stages
across the impact pathway to ensure the desired impact is
realized” (Session 3Cii). This approach was amplified in
Keenan’s presentation where he explained that at the
CSIRO, they believe the whole organization is responsible
for impact, and the relationships built with end users/
stakeholders should be long-term, if possible, and built on
trust.
In session 7, a team from Alberta described The Al-
berta Health Services (AHS) Innovation Pipeline (Fig. 2).
Here, the co-prioritisation process involves a compre-
hensive network of stakeholders who identify gaps in the
care provided. This goes further than many other ap-
proaches, because the co-design informs a search for
existing R&I that might address the needs, as well as
topics for new research. Tim Murphy (Session 7A) de-
scribed the importance of moving towards open models
of innovation with wide participation to bridge the Im-
plementation to Impact gap.
The AHS has created various Strategic Clinical Net-
works (SCNs). In session 7B, Nancy Fraser from the
Critical Care SCN described how in Alberta’s Partner-
ship for Research and Innovation in the Health System
(PRIHS) all members are part of the network “coming to-
gether to solve problems and advance care….a bi-
directional dialogue that allows the health system to
identity gaps and feed them into the research community
to help solve” (7Bi). Building on this, Jeffrey Crelinsten,
Moderator of session 7, recommended the following ac-
tion to Summit delegates and the R&I community more
broadly: “actively engage patients, service providers and
payers with researchers in the identification of gaps and
problems and in the development and testing of solu-
tions” (7F).
As set out by Murphy in his introductory welcome to
the Summit, AI believes more is achieved by working to-
gether across sectors covering many fields. Therefore, in
addition to the work in the health field, other aspects of
AI’s approach were described, as were links with a paral-
lel organization, Emissions Reduction Alberta (ERA). In
session 2, Elizabeth Shirt described the importance of
collaboration for ERA in enabling it to address chal-
lenges (2Cii), and explained it also takes a portfolio
approach – working on some innovations that can be
implemented rapidly to meet a need, and recognising
that others will take longer reinforcing the importance
of stakeholder relations for successful implementation
and subsequent impact sustainability.
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Component three: set and monitor ethical standards for
(health) R&I and research partnerships
The issue of research ethics is important across scientific
fields, and often particularly so for health research. The Inter-
national School on Research Impact Assessment (ISRIA)
statement was made available at the Summit and provides a
10-point guideline for an effective process of research impact
assessment [1]. Point eight covers ethics specifically in rela-
tion to research impact assessment by saying: “Anticipate
and address ethical issues and conflicts of interest”.
Also, in relation to Implementation to Impact, during the
discussion following the presentations in session 4, Jean
Miller referred to an especially pertinent document on the
ethics of engaging patients in research [17]. This Draft Eth-
ics Guidance was developed by a CIHR Working Group
made up of patients, researchers and ethicists, and is
intended as an educational resource primarily for patients
and health researchers, as well as research institutions and
funders of research. The Guidance focuses on ethical con-
cerns that need to be addressed to maintain trust in re-
search partnerships across the research lifecycle. A public
consultation on the Draft Ethics Guidance ran from No-
vember 26, 2018 to February 25, 2019 and the feedback re-
ceived during the consultation was reported as being used
to inform the final version of the document [17].
Component four: monitor and evaluate the (health) R&I
system
The monitoring and evaluation (M&E) component in
the original Pang et al. (2003) framework [9] was located
here in the sequence rather than at the end. This is now
of crucial importance for this report because it demon-
strates how those working in R&I systems can be en-
couraged to realize that impact will be a major element
of the M&E system. This, in turn, provides both incen-
tives and justifications for focusing on activities likely to
maximize impacts. This was one of the Key Messages in
the presentations from Hanney (1Biii) and others on im-
pact frameworks.
Hanney described in session 1B that the creation of
the Payback Framework in the 1990s [18] involved add-
ing the assessment of wider societal impacts to the trad-
itional assessment of academic excellence that primarily
focused on knowledge production and research capacity
building. The Payback Framework was informed by earl-
ier UK research that pioneered concepts around collab-
orative agenda setting between potential users of
research and the researchers [19] and this led to Han-
ney’s Key Message that: “Impact assessment frameworks
such as the Payback Framework are informed by models
of collaboration and implementation” (1Bi). The Payback
Framework provides a combination of the various cat-
egories of academic and wider benefits or impacts, with
a model of how to organize their assessment. In practical
terms, this framework is then used to inform the various
methods that can be used to assess the impact, including
documentary analysis, surveys, interviews and case stud-
ies – see Hanney et al. (2013) for examples [20].
The original Pang et al. (2003) framework for Health
Research Systems [9] incorporated the assessment of
Fig. 2 The Alberta Health Services (AHS) innovation pipeline. Adapted from AHS Research Strategy, 2012 [16]. Reproduced with permission
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wider impacts from the Payback Framework, which also
helped to inform the Canadian Academy of Health Sci-
ences (CAHS) framework developed by a committee
chaired by Alberta’s Cy Frank. Graham explained how
the CAHS framework: “built on the Payback Frame-
work’s academic and societal impacts; provides a com-
mon set of tools, including indicators; identifies pathways
to impact across the five payback categories…” (1Biv). An
account of how the CAHS framework has been applied
is available in the proceedings of a forum held in Alberta
in 2015 for delegates from across Canada [21].
In session 7A, Murphy argued that in order to meet
various requirements along the Innovation Pipeline
(Fig.2), it would be necessary to replace the traditional
“fund and forget” funding model with a new type of
“value hunter/value optimizer” R&I funder. The focus
would be on value generation complemented by an as-
sessment approach that includes “indicators and metrics
which give line of sight to the intended impact – and we
can measure it” (7Aii). In session 9a, Alan O’Connor
and Kathryn Graham shared the impact assessment
framework used to assess the socioeconomic return on
the investment in the PRIHS program described above
by Fraser as part of the Innovation Pipeline. They noted
that, “Having a shared vision of impact sustained the
partnership over the years” (9Ai). Their presentation fo-
cused on three components of the impact assessment
framework. First, the ‘stage gate approach’ to support
decision making across the R&I life cycle as reflected in
the pipeline. Second, the impact framework to monitor
and evaluate which includes an economic model and
performance measures for assessing scale up and spread
of R&Is for social returns including improved patient
health. And third, communicating results, which in-
volves a scorecard and “impact narratives” (9Aiii).
As noted above, some R&I funders are not only building
impact assessment approaches that encourage a focus on
impact throughout research and implementation pro-
cesses, but also engage stakeholders in developing the im-
pact assessment approach. In her presentation, Radó-
Trilla from AQuAS explained how the organization’s
SARIS approach incorporated the “Need to move from an
excellent-centered policy to a mixed strategy of excellence
and impact” (Session 3B). The SARIS approach is closely
linked to the ISRIA Statement that was authored by an
international team led from AQuAS [1]. The impact nar-
ratives developed under SARIS to provide accountability
can then be analysed to provide lessons from a specific
funding stream for future R&I investment opportunities.
There is a challenge to engage parts of the evaluation
community to adopt the new approaches to research
assessment.
Summarizing lessons learned from other research fun-
ders that would be relevant for the NIHR’s approach to
impact [22], Kamenetzky concluded that “engaging re-
searcher communities & wider stakeholders should be at
the core of impact pathway planning, and subsequent re-
search impact assessment” (1Cii). Furthermore, he ar-
gued, it was important to recognize the benefits that
could come from assessing impacts, including “greater
mutual understanding between funders and researchers,
improved communications, and better evidence of value”
(1Civ).
The focus of session 9 was engaging stakeholders in
assessing and improving impact in order to sustain it. In
session 9B, Maxi Miciak from AI described a Canadian
collaborative approach to develop an assessment frame-
work for health services and policy decision-making.
The aim was that the inclusion of many organizations in
developing a shared framework would increase the likeli-
hood of it being adopted [23]. Miciak and Graham, in
collaboration with CIHR and its Institute of Health Ser-
vices and Policy Research (IHSPR), played a central role
in coordinating the collective work of Alliance members
in developing the assessment framework; in her presen-
tation Miciak highlighted the importance of the collab-
orative approach as taken here. Her first Key Message
was, “Co-development and implementation of impact
assessment frameworks and plans fuel stability through
confidence, resonance, and relevance” (9Bi). She also ob-
served that, “Different groups are at different stages of
readiness in terms of need, capacity, and ability, so pro-
viding options for engagement with impact assessment
will promote sustainable scale and spread of impact as-
sessment” (9Bii).
Similarly, in session 9D Carrie Hough and Adam
Kamenetzky explained how a new Global Health Re-
search programme from England’s NIHR is aiming to
design a monitoring, evaluation and learning approach
to maximise sustainable impact. The NIHR is seeking to
“collaboratively identify pathways to impact; establish
mechanisms for testing whether these pathways do or do
not work; identify emerging lessons to feed into portfolio
development; and, embed monitoring evaluation and
learning considerations throughout the portfolio” (9Di).
Hough and Kamenetzky discussed adopting a portfolio
level Theory of Change to inform the next steps and em-
phasized the importance of collaborations to develop the
framework. In his moderator’s Actionable Insights for
session 9, the UK’s Ovseiko stated in his first Insight:
“Canadians in general and Albertans in particular have
developed not only world-class, but in many respects,
world-leading expertise in implementation to impact. It
builds on learnings from the world’s best practice and is
attuned to their unique context and needs” (9E).
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Component five: secure funding for research and R&I
system building
In the context of this report, the key resource issue is
not just the money to conduct research, but also, in par-
ticular, the resources required by (health) R&I systems,
and funders, to undertake the various steps to encourage
implementation and impact and, accordingly, the appro-
priate assessment of impact resulting from investments
in R&I. Kamenetzky highlighted the importance of re-
source allocation for successful and sustainable imple-
mentation and impact in his Key Messages to funders:
“consider upfront the resources required for embedded,
relevant and methodical approaches to impact & its as-
sessment” (1 Ci).
This message was amplified by Ovseiko, who argued
“As more information on the use of the established
frameworks and approaches is becoming available and
the development and implementation of new ones is con-
tinuing, it is becoming even more important for funders
to commit sufficient resources to the assessment of re-
search impact as well as to the implementation of re-
search into practice” (1D). After the speakers had
described the work their respective organizations were
undertaking to promote implementation and impact
assessment, some discussions focused on practical ques-
tions about the resources available to conduct such ac-
tivities. Generally, the presenters said their teams and/or
budgets were small, but while they could do with more
resources, they were all making progress. And, as em-
phasized by Reesa John from AI, it is important for R&I
funders who adopt an approach that could be described
as being ‘comprehensive and coherent’ to identify and
show the value of their approach in order to justify their
investments.
Component six: build, strengthen and sustain the human
and physical capacity to conduct, absorb and utilize
(health) research
Pang et al. 2003 included building the human and phys-
ical capacity to absorb and utilize health research as part
of the capacity building function in their original frame-
work for a health research system. These aspects of cap-
acity building were discussed at the Summit, along with
promoting gender equity in R&I and the key contribu-
tion that health service data can make to the production,
use and spread of relevant research findings and impact
assessment.
The importance of developing sufficient capacity was
highlighted in Ovseiko’s opening presentation in session
1: “Implementation to impact is more of an art than a
science: there are many useful tools, but implementation
success ultimately depends on the capabilities of local
staff to operate in complex systems” (1Ai). Session 5 was
devoted to various aspects of building the capacity for
Implementation to Impact, mostly but not entirely from
the perspective of activities underway in the health field.
In session 5A, Meghan McMahon described the role
of the Health System Impact Fellowship program funded
by the Canadian Institutes of Health Research – Institute
of Health Services and Policy Research (CIHR-IHSPR)
[24]. This scheme is attempting to respond to the
changes in PhD graduate employment trends, and the
emergence of learning health systems. It is preparing
PhD trainees and post-doc fellows for success and im-
pact in a range of roles within and beyond academia. Ac-
cording to McMahon, emerging lessons from assessment
of the capacity development program “suggest five ‘pro-
gram ingredients’ are helping prepare fellows for stronger
and more diverse careers: experiential learning within a
health system organization, protected time for academic
research, co-mentorship from health system and aca-
demic leaders, professional development training allow-
ance, and participation in a national cohort” (5Aii).
On a similar theme, Alex Clark (Session 5B) described
how the increasing attention on impact in post-
secondary institutions meant there was a need to create
“cultures that support and incentivize impact” (5Bi). He
argued that impact skills need not be separate streams of
professional development but claimed “Policy and
experts recommend that training and support be pro-
vided for impact across the career trajectory, including:
to graduate students, post-doctoral fellows and re-
searchers. Individuals enhancing their skill should engage
in professional networks” (5Biii).
Diverse aspects of R&I capacity building were also fea-
tured elsewhere in Summit discussions. For example,
Hough and Kamenetzky described the Global Health Re-
search programme from England’s NIHR where stake-
holders are exploring ways to establish “proportionate
monitoring and evaluation systems that support further
capacity building for implementation and impact activ-
ities across the portfolio” (9Diii). In session 7 on the
Innovation Pipeline, Gabrielle Zimmermann from the
Alberta Strategy for Patient Oriented Research SUP-
PORT Unit (AbSPORU) Knowledge Translation (KT)
Platform described how one of the key initiatives of the
platform “is to advance implementation science in Al-
berta. We do this in part by providing advice and assist-
ance with the practical application of implementation
science, but we are also exploring the development of an
implementation science lab for long-term impact” (7Di).
She explained how the Platform operates at the mid-
dle to end of the Innovation Pipeline (Fig. 2), and
how Implementation Science labs “can help build re-
lationships and lay the foundation for robust pro-
cesses within the healthcare system” (7Diii) that
support successful scale and spread of innovations
for impact.
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Capacity building for R&I broadly defined includes
provision of infrastructure support. Laura Hillier described
various ways in which infrastructure funding from the
Canada Foundation for Innovation (CFI) supports the
scale and spread of innovation in any field. It can be used
strategically to build or support expertise and leadership
in selected research areas, for example CFI supports the
Ocean Tracking Network. This is a global research, tech-
nology, data-management and conservation platform
headquartered at Dalhousie University in Halifax, Nova
Scotia. The network supports research documenting the
movements and survival of more than 130 species of
aquatic animals carrying various types of electronic tags.
Hillier’s first Key Message added to the major Summit
theme of collaboration by stating: “It is through strong col-
laboration linkages that new ideas become innovations
and yield benefits to Canadians – research infrastruc-
ture can stimulate and support these collaborations”
(2Bi).
Two presentations focused on the specific issues
around how promoting greater gender equity should en-
hance research impact. In session 5C, Ovseiko set out in
considerable detail the evidence to support the idea that
increasing gender equity should: “Increase reproducibil-
ity of basic research” (5 Ci), “Enhance translation of clin-
ical research” (5Cii) and “Maximize the potential of the
scientific workforce” (5Ciii). He also made recommenda-
tions for research funders, institutions and evaluators by
drawing on the paper he co-authored with a large team
of international experts on how to include and
strengthen analysis of gender equity in research impact
assessment [25]. That team developed the approach, or
tool, called the four ‘As’ of research impact assessment
with regard to gender equity (Fig. 3).
Building on this call for action, Eduard Güell from
AQuAS argued that the research impact agenda would
continue to be incomplete unless the gender perspective
is introduced, and female talent optimized. He claimed
that there was a link between women’s participation in
health science and attention to gender related and sex-
related factors in disease-specific research. He described
an ongoing project on the gender perspectives in bio-
medical science in Catalonia organized around the 4 ‘As’
of research impact assessment developed by Ovseiko
et al. (2016) [25] and described above. He claimed: “our
pilot in mental health helps us to see our own bias and
the importance of including a gender perspective when
assessing research impact” (5Div).
In commenting on the work from AQuAS, Kame-
netzky suggested: “Equity of impact cannot be achieved
without efforts to understand and take action to address
inherent and systemic biases: the work of AQuAS showed
that while ‘looking into the mirror’ (to explore issues of
gender bias in R&I) could be challenging, there was clear
value in holding organisations to account, if collectively
we are to move from being blind to these biases” (5E).
Finally, one panel at the Summit focused entirely on
data strategies and analytics that address data use. In-
creasing access to relevant data can be an important part
of improving the capacity to conduct, scale-up and as-
sess R&I. Dale Sanders’s presentation entitled, Data-
driven insights for accelerating scale-up and spread, de-
scribed many problems with the accuracy and access to
US healthcare data. He called for an acknowledgement:
“that every piece of data that is collected as a conse-
quence of healthcare delivery, is an artefact of data that
ultimately belongs to the patient – not healthcare sys-
tems, researchers, governments, or clinicians – and
should be shared and utilized to its fullest value for the
benefit of patients” (8Aiv). Alba Velasco Trujillo from
SIRIS Academics described the approach developed at
SIRIS to advance analytics for R&I assessment: Semantic
technologies and ontology-based data access for research
impact monitoring and evaluation. SIRIS recognizes the
importance of data in evidence-based policy but identi-
fied that often there are challenges such as a lack of inte-
gration of existing data. New approaches, such as open
data, are providing ways of addressing the challenges.
For example, SIRIS has applied the new approaches to
research innovation and impact assessment: “Semantic
Technologies solutions offer a disruptive toolkit to support
the integration of data that are currently dispersed and
highly heterogeneous and ensure they are accessed in an
integrated, unified and semantically consistent way”
(8Biii).
Fig. 3 The Four “As” of research impact assessment with regard to
gender equity. Source: Ovseiko et al. (2016) [25]
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The data landscape in Canada includes several high
functioning cross-jurisdictional data sources and plat-
forms. Nevertheless, according to Rick Glazier from
CIHR-IHSPR, the situation is “mainly characterized by
fragmentation and lack of comparability between and
within sectors” (8 Ci). Recently, there has been increasing
recognition of the importance of healthcare data to re-
search, though Glazier cautions “Much work is needed to
regulate, govern, set standards, remove access barriers,
and harmonize digital health, community and social ser-
vices data in Canada” (8Ciii). Commenting on the work
required to improve the data landscape, Dale Sanders
advised delegates that: “Every strategy for becoming “data
driven” should dedicate a significant portion of the strat-
egy and project plan to building trustful relationships
with those affected by the data… both the providers of
data and the consumers of the data” (8D).
Component seven: produce scientifically valid (health)
research outputs
Various presenters, including Hanney and Graham (1B),
in relation to the Payback Framework and CAHS Frame-
work respectively, as well as Keenan (3C) and Radó-
Trilla (3A) emphasized the continuing importance of
traditional research outputs (e.g. scientific publications)
when an additional evaluation focus is added to assess
the wider impacts of R&I.
The importance of the production of scientifically valid
outputs was central to the presentation by Wendy Reij-
merink from ZonMw in the Netherlands (Session 9C).
While she also described ZonMw’s approach to encour-
aging impact (see next component), she emphasized the
importance of first focusing on the quality of the research
production along with the societal relevance: “Don’t talk
about impact when the underlying evidence is not robust
in terms of relevance and quality” (9 Ci). These comments
were made in the context of a stream of work in The Lan-
cet related to the claim originally made by Chalmers and
Glasziou (2009) [12] that estimated the annual avoidable
waste in research production and reporting was up to
85%. A further series of papers in 2014 [26–28] discusses
the five stages of waste in research, including: the rele-
vance of the questions; the design, conduct and analysis;
and non-publication. In her presentation (9C), Reijmerink
then highlighted the Consensus Statement from The En-
suring Value in Research (EViR) Funders’ Collaboration
and Development Forum [29]:
 “we set justifiable research priorities;
 we require robust research design, conduct and
analysis;
 we seek to ensure that research regulation and
management are proportionate to risks;
 we seek to ensure that complete information on
research methods and findings from studies is
accessible and usable.”
She drew on them when describing the ZonMw frame-
work for fostering responsible research practices that
covers the various elements in the funders’ Consensus
Statement. These include setting justifiable research pri-
orities that should ensure that the questions are relevant
to the users of research [30]. To this, the concept of pro-
ductive interactions is most helpful [31].
As noted in Component Two, many of the presenta-
tions on the engagement of patients and other stake-
holders emphasized that such engagement helps
improve the relevance of the research priorities. But it
goes further, and various presentations also argued that
later stages such as the conduct of research and produc-
tion of valid outputs were also improved by stakeholder
engagement. To facilitate this, Gerlach at Academy-
Health advises organizations contemplating patient en-
gagement to consider “How might traditional definitions
of evidence (including what’s considered rigorous) need to
change to better incorporate patient narratives, insights
from local communities, and other important data
sources?” (4 Ci). Likewise, Murphy stipulated “A re-
engineering of the current evidence production process is
required and will assist and support more effective pro-
duction, dissemination, and implementation of research”
(4D).
Component eight: communicate and promote research to
inform (health) policy, practices and public opinion and
to develop tools (drugs and devices) to improve health,
society and the economy
In the opening keynote presentation Ovseiko set the
scene for the complexities involved in Implementation to
Impact and referred to it as being “more of an art than a
science” (1Ai). In the second World Café session, Ad-
dressing Sustainability in Real-world Applications, con-
tributors identified a series of reported barriers to
sustaining efforts to implement R&I results into real-
world contexts. In addition to difficulties in monitoring
and evaluating progress, the session moderators from
Alberta, Kelly Mrklas and Rachel Flynn, reported: “con-
textual barriers such as: resourcing (costs drive the deci-
sion making); implementation and learning climate (e.g.
the complexity of health systems; silos within and across
the healthcare system that prevent individuals from
learning from one another around issues of common and
mutual concern); and implementation readiness and cul-
ture (i.e. moving past the traditional “pilot project” men-
tality and shifting to longer lines of sight involving scale,
spread, sustainability and impact)” (6Biv).
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Many of the above issues relate to the organization
within which the implementation solution and its sus-
tainability is supposed to be taking place. Mrklas and
Flynn additionally argued that “The people part of
change” (6Biii) was a key consideration, and this point
was also emphasized by Dale Sanders, who proposed
that “Every investment strategy in innovation should in-
clude an evaluation of its likelihood of adoption based on
the fundamentals of human behavior” (2D).
Various presentations at the Summit focused on as-
pects of encouraging implementation, and what could be
achieved by developments in research systems as well as
systems in which research results are implemented.
There were descriptions of holistic, or system-wide, at-
tempts to increase implementation, scale and impact,
and accounts of the importance of culture in achieving
implementation and impact. Such points were brought
together in one of the World Café sessions: “To influence
the system to perform better at ‘capturing the benefit’ the
government needs to: achieve a balance of encouraging,
enabling and enforcing, e.g. supporting culture changes
and providing resources, but also holding people to ac-
count and being willing to shut down things that aren’t
delivering” (6Aiii).
Two presentations used the metaphor of a house. While
they did so in different ways, both were appropriate for
highlighting the need for the type of ‘comprehensive and
coherent’ approach described earlier as a key feature of
effective R&I systems that will translate research findings
and achieve the range of impacts. Session 3 focused on
the role of stakeholder engagement in culture change. In
the first presentation, Reesa John described AI’s Integrated
End to End Impact Management System, in a presentation
entitled, Creating an organizational culture to move imple-
mentation to impact. She emphasized that researchers need
to remember their “project exists within a system that is
made up of a community of people” (3Ai), it is culture that
“has the power to unite that community to ignite and inspire
impact” (3Aii), and that “Integrating a Culture plan up front
as part of your Impact plan is critical to success” (3Aiii) in
achieving broader impact. In describing “the house that im-
pact built” she suggested that culture could provide the
frame for the house and within that there would be many
elements which organizations can construct to achieve im-
pact. These include an integrated end-to-end impact man-
agement system, mechanisms to support system
coordination and partnerships across stakeholders and sec-
tors (e.g. collaborative funding programs, adoptions of new
requirements and opportunities for training in integrated
knowledge synthesis and stakeholder engagement), coordi-
nated investment portfolios in focused areas, and an impact
assessment strategy including evaluation.
In their presentation on NIHR’s approach to evaluating
the impact of the health research funded by the Global
Health Research programme, Hough and Kamenetzky also
described the importance of culture. They explained how
“Activities to create an ‘impact culture’ for this work by en-
gaging across the various points of the health research sys-
tem have initially focussed on participatory activities with
research applicants…and peer review committee members”
(9Dii). Just as John had done, they stressed the importance
of working in a community, but in this case illustrated the
point by showing that the community of a village was
stronger than an individual house.
The importance of culture in Implementation to Im-
pact also featured in Keenan’s presentation. He de-
scribed CSIRO’s impact framework which covers the full
spectrum of activities from initial engagement (as noted
for Component Three) and inputs, which can be con-
trolled and planned, through to those such as outcomes
and impact on which the funder has less control. Never-
theless, “Effective planning for impact is crucial for the
ultimate delivery of that impact through the uptake &
adoption of research ‘babies’” (3 Ci). He also described
how CSIRO had been working on developing long-term
relations with users for 10 years, and that “Embedding
impact culture in research organisations takes time –
and requires both ‘top down’ & ‘bottom up’ approaches”
(3Ciii). In the opening session, one of Kamenetzky’s ob-
servations for the NIHR from the approach of other fun-
ders was: “Take time: orienting research to societal and
economic domains of impact is a long-term process of
strategic change for funders and researchers” (1Ciii).
The continuing thread across Summit speakers that
stakeholder engagement in R&I systems facilitates imple-
mentation and impact is also seen in the Ontario Brain
Institute’s approach to stakeholder engagement. First,
“Co-developing tools and resources for patients empowers
them with knowledge, levels the perceived power dy-
namic, and supports their ability to become active part-
ners in their own treatment and care” (4Bii). But it goes
further than this because “Developing partnerships with
community-based organizations extends the reach of
these tools and helps scale and spread knowledge from
the bottom up” (4Biii).
Reijmerink’s presentation illustrates how ZonMw (de-
scribed previously) is fostering responsible research to
maximize sustainable impact in terms of observable use of
valuable evidence, promoting for example the adoption of
real-world quality/innovation cycles in its programming
processes. Her third Key Message proclaimed: “Smart
funding agencies steer on accumulation of small wins,
aimed at better health and healthcare for all” (9Ciii).
While building the structures to enhance Implementa-
tion to Impact can take a long time, one of the aims of
the activities stressed in various presentations is to speed
up as well as increase the processes that facilitate imple-
mentation. This aim featured in Elizabeth Shirt’s
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presentation on the work of ERA in developing clean
technology in Alberta (Session 2C). She introduced
Summit delegates to a series of Technology Readiness
Levels (TRLs) and the three elements that needed to be
brought together to make progress along those levels.
She called the three: Toolset; Team-set; and Mindset.
Her emphasis on the importance of collaboration, as de-
scribed in Component Two, was part of the team-set
element. She described how the toolset included: “tools
to identify and accelerate technologies (and companies)
along the TRL scale towards commercialization” (3 Ci).
The Summit session Accelerating Scale and Spread for
Sustainable Impact – A Local Approach (Session 7) em-
phasized the importance of attempting to reduce the
time taken to realize wider benefits from R&I. In that
session, Murphy added to his points noted previously
about the importance of moving towards open models
of innovation and a changed role for funders, by consid-
ering the game changing impact of emerging technolo-
gies (such as personalized healthcare) on the Innovation
Pipeline (Session 7a). He argued: “These technologies
wrap around innovation in unique and cumulative ways,
which accelerates the initiatives in the pipeline towards
impact. The role of the funder and the funding models
will need to permit the collisions to occur, to embrace
new, open models of innovation” (7Aiii).
Fraser described the various steps along the
Innovation Pipeline from the perspective of the
health care system. The initial steps of collectively
identifying care gaps in Alberta Health Services, and
identifying or funding research to address them,
were described in Component Two, but remaining
steps are outlined here. In Step 3, she stated: “we
‘test’ what we have developed; funding sources serve
as an enabling function to help move work down the
pipeline shown in [Fig. 2]. What is learned at each
stage of the pipeline circles around and informs the
‘science’” (7Bii). In Step 4 proven innovations are
spread to scale, and in Step 5 they are implemented
and sustained in care. Her final Key Message
reflected this, and highlighted a contrast with the
earlier steps when researchers had more involve-
ment: “As work moves to adoption and sustainability
within the health system the clinical and operational
leaders assume more of a lead to ensure the sustain-
ability of the gains that have been discovered and
are now being used” (7Biv).
The specific example Gregg Nelson provided in his
presentation (Session 7C) strengthened the general ac-
counts from the Albertan team. He showed how the
success of the Enhancing Recovery After Surgery
(ERAS) approach in Alberta could be described in
terms of the five steps in the AHS Innovation Pipe-
line (Fig. 2). The Surgery SCN identifies care gaps as
the first step. For the second step of identifying evi-
dence, or funding research to produce it, the SCN
draws on the work the multi-professional inter-
national ERAS Society. The work of the Society is
aimed at developing perioperative care and improving
recovery, and in one analysis, had been shown to re-
duce length of stay by 2.5 days and reduce complica-
tions by 50%. For Step 3, the “Implementation ‘Test’
in Alberta”, the Surgery SCN received a PRIHS grant
from AI (formerly Alberta Innovates – Health Solu-
tions) in 2013 to apply the approach to colorectal
surgery in Alberta. This proved successful [32] and
they proceeded to Step 4, “Implementation (Work to
Scale)” in which they received further funding from
2016 to 18 to spread ERAS to additional locations
and care pathways. The Surgery SCN have now
reached Step 5, “Implemented and Sustained in Care”,
with Nelson stating: “This started as a proof of con-
cept project in colorectal surgery and since that time
has evolved into a province-wide operationalized pro-
gram now in multiple surgical areas and multiple
hospitals” (7Ciii). This case study provides a good ex-
ample of how a global evidence-based approach was
implemented locally with additional funding to de-
velop and apply the approach in the AHS.
Finally, in session 7, Mrklas and Flynn’s analysis of the
role of the pipeline highlights: “The importance of both
the pipeline to orient change, investments in change, in-
tent to scale-spread, sustain, and make impact, and of
co-design in healthcare settings” (7Ei). Additionally, they
went on to stress that: “Implementation and sustainabil-
ity have much in common – recognize the importance of
sustainability in the pipeline to impact, and the need for
research to fill sustainability knowledge gaps” (7Eii).
In this component, we have seen both accounts of
how long it takes to build up a system to encourage Im-
plementation to Impact and attempts to speed up the
processes from research to implementation and impact.
One of Ovseiko’s insights as moderator of session 9 pos-
sibly provides a way to bring these concerns together to
some degree. He referred to the “‘Push the Pace’ ap-
proach at NIHR to continuously improve its processes”
(9E). This project was an attempt to speed up the re-
search and implementation processes through the NIHR
examining its own processes and making improvements,
initially as a one-off but with the intention that it should
become a process of continuous improvements (see
Moran et al., 2019 [33] for a fuller account). Other pre-
senters also referred to continuous improvement ap-
proaches, including Elizabeth Shirt who included
continuous improvement in the third element of her ap-
proach, i.e. as part of the Mindset (2Ciii). As with the
Push the Pace initiative, continuous improvement ap-
proaches are likely to operate at a systems level.
Hanney et al. BMC Proceedings 2020, 14(Suppl 6):10 Page 16 of 22
Section two: discussion of emerging themes and
challenges
Developing comprehensive and coherent systems
promoting implementation to impact
Contributions made at the Summit support the view that
globally there is increased interest in the benefits that can
accrue from adopting a systems approach to (health) R&I.
This was seen in particular, but not only, in the presenta-
tions at the International Summit from five large funders
at national or regional levels, spread over three continents:
AI, AQuAS, CSIRO, NIHR and ZonMw. In each case, the
presentations from delegates from these organizations de-
scribed activity, and progress, associated with Implementa-
tion to Impact across various components listed in the
WHO framework [9]. This illustrates that when the vision,
stakeholder engagement in agenda-setting (supported by
appropriate ethical considerations), M&E, availability of
resources and capacity building are all aligned and ori-
ented towards producing and implementing robust and
relevant evidence, then sustained innovation and impact
seem more likely to be achieved. These funders are all
moving towards some of the key desirable characteristics
of a successful health research system that were identified
in a recent review for WHO [10].
Several presentations stressed that the existence of an
impact culture was vital in achieving sustainable impact,
but it is probable that such a culture is likely to be fos-
tered when the various components are all aligned to-
wards achieving sustainable impact. For example, if the
M&E, or assessment, of the research includes a focus on
rewarding efforts to implement research and generate
impacts, then this provides both incentives and a justifi-
cation for spending time on such activities, which in
turn will help foster and sustain an impact culture. The
elements become mutually reinforcing and illustrate
how appropriate structures can work positively with the
human factors. The presentations in session 3 (John,
Radó-Trilla, Keenan) and 9D (Hough and Kamenetzky)
illustrate how whole systems could be geared up towards
an impact culture. Keenan elaborated on how some of
the ways of embedding an impact culture in the research
organization could be top-down, including the invest-
ment decisions and the evaluation approaches. Others
could be bottom-up, for example, co-developing impact
pathways and monitoring plans with key stakeholders, as
well as developing positive relations with users (3C). The
capacity building component of a research system could
also be seen as a bottom up approach to developing an
impact culture.
Such presentations, plus others from organizations such
as AI and NIHR, also illustrated the enthusiasm, even in-
spiration, which can be generated by working collabora-
tively within an organization adopting a systems approach
to promote Implementation to Impact. This was seen
perhaps most clearly in the series of presentations in ses-
sion 7, Accelerating Scale and Spread for Sustainable Im-
pact – A Local Approach. Each presentation focused on
different aspects of the Innovation Pipeline shown in Fig.
2. The cumulative effect of the series of diverse presenta-
tions on a shared approach was especially powerful, as also
reflected in the first action recommended by Crelinsten:
“promote the use of the pipeline concept and provide train-
ing on its use to key stakeholders” (7F).
Embedding the research system into the (healthcare) user
system: feasibility and supporting implementation to
impacts
Those R&I funders that have gone furthest in developing
a research system to promote Implementation to Im-
pacts, also often seem to be pioneering attempts to build
the research system into user communities or systems.
Keenan (Session 3C), for example, described how in
Australia CSIRO are attempting to do this across the
range of fields in which they operate. It is particularly
noticeable, however, as a feature of the pioneering work
of the health R&I systems and the relevant healthcare
systems highlighted at the Summit.
This combined approach in relation to the health field
was most clearly described in the accounts above of
several presentations in Summit session 7 on the
Innovation Pipeline, including Fraser’s account of all
members of the PRIHS project being part of a network
“coming together to solve problems and advance care”
(7Bi). Zimmermann’s account of the KT Platform estab-
lished in Alberta by the AbSPORU explicitly stated the
“Implementation Science (IS) labs are research teams em-
bedded into the health care system to conduct studies
using real world data to inform best practices” (7Dii).
Furthermore, as noted in the discussion in session 7, Cy
Frank, when directing AI’s health research, served on
the Advisory Committee of the NIHR-funded review of
the global literature on the improved healthcare per-
formance of research active healthcare organizations. It
was reported in 2013, but the related article was Boaz,
et al., 2015 [34]. Such evidence on the benefits of re-
search active healthcare organizations was compatible
with Frank’s own initiatives in Alberta.
McMahon’s account of the CIHR-IHSPR’s Health Sys-
tem Impact Fellowship program (Session 5A) illustrates
the increasing efforts across Canada to build research
into healthcare systems. The program was, in part, a re-
sponse to the emergence of “learning health systems”
(5Ai). Early findings from the evaluation of the program
have found “Health system organizations are keen to
embed PhD talent as part of their teams, and PhD
trainees and post-docs are keen for impact-oriented
training opportunities” (5Aiii).
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Addressing the challenges to implementation to impact
and tensions identified
In addition to discussion of promising practices in imple-
mentation and impact, Summit deliberations also explored
key challenges and tensions facing Implementation to Im-
pact, and the role of a systems approach in facilitating
some ways to address them. Key examples of the chal-
lenges and tensions are analysed below.
a) In various presentations, issues were raised about
how to reduce the many years often taken to
achieve implementation and realize impact in R&I.
As was seen in the presentations from session 7, the
drive to accelerate Implementation to Impact was
often associated with attempts to take coordinated
action aimed at various components of the system.
For example, engaging stakeholders throughout the
processes is more likely to generate the
circumstances in which the R&I system meets the
needs of the local user system. Concerns were
raised, however, in other sessions about how far the
resources would readily be available to fund the
activities within the system designed to build the
internal capacity and structures necessary to
promote innovation and impact. Furthermore, while
presentations such as those from Kamenetzky (1C)
and Keenan (3C) showed a keenness to promote
greater engagement and impact, they also
recognized that developing the structures, processes
and relationships to do this could take research
funding organizations considerable time.
Additionally, Reijmerink from ZonMw, which has
made considerable efforts to improve
implementation and impacts, made the usefully
realistic point in session 9C, as noted above, about
the “accumulation of small wins” (9Ciii). This
illustrates the point that there might be a need to
negotiate between “speed” and “timeliness”.
Similarly, lessons come from a detailed exploration
of how to analyse the time taken from initial
research to translation into improved policies and
care [7]. The various case studies analysed reveal
enormous complexities, and also differences in the
opportunities to reduce the time. This reinforces
the need for careful analysis and adaptive strategies
when developing plans to speed up the processes of
research and implementation. Additional workloads
often lead to increased tensions.
b) Challenges and tensions arise from the inevitable
resistance to change. In this report we are primarily
describing what was said about how the R&I system
itself might be able to address such challenges.
Various aspects of the challenges in organizations in
which innovations are being implemented might be
beyond the R&I system to address. (Nevertheless,
the more firmly the research system is embedded
into the user organization, perhaps as with AI and
AHS in Alberta, the better). More pertinent to our
analysis is the resistance that might arise in the R&I
system itself to changes related to developing some
of the components necessary in a system geared up
to emphasize Implementation to Impact. Various
presenters, including Hanney (1B) and Radó-Trilla
(3B), gave examples of such resistance. Here, the
various points made above about careful attention
to developing an impact culture could be helpful in
reducing the tensions.
c) Coproduction in R&I is one area where resistance
to change is, at least in part, based on genuine
difficulties in developing new approaches. Ovseiko’s
opening Key Note presentation drew attention to
the important issues raised in a recent article by
Oliver et al.: The dark side of coproduction: do the
costs outweigh the benefits for health research?
Oliver et al. (2019) offer advice as to when and how
to consider coproduction [35]. Such issues are
probably best analysed within a systems approach.
d) As noted by Reijmerink, it is important to focus on
the quality of the research production before
considering implementing the resulting findings:
“Don’t talk about impact when the underlying
evidence is not robust in terms of relevance and
quality” (9 Ci). So, in addition to the general
challenge to research funders and organizations to
avoid the previously reported high rate of research
waste, there are particularly acute concerns when
the evidence produced is being considered for
implementation. Not necessarily every aspect
associated with research waste could be addressed
by developing strong research systems.
Nevertheless, many of the actions described above
as fitting into a system would improve the quality
of research. These include the efforts to identify
research agendas relevant to the needs of users,
appropriate research ethics procedures, and
developing the capacity of researchers. Again,
however, some of the steps to improve quality will
require additional resources and time.
As also noted, Reijmerink’s presentation introduced
the Consensus Statement from the EViR Funders’
Forum which sets out approaches to improve
research quality. Interestingly, aspects of the work
of all three of the health research funding bodies
that created and co-convene the EViR Forum were
described at the Summit. While only the presenta-
tion from Reijmerink based at ZonMW specifically
mentioned the Forum (Session 9C), the other two
funders were NIHR, several of whose other
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initiatives were described, and PCORI, whose work
on stakeholder engagement was described in Ger-
lach’s presentation (Session 4C). This might illus-
trate that well-organized research funders adopting
a systems approach tend to be interested in ad-
dressing a range of challenges. They might also
adopt a leading role as credible change-makers in
value-driven knowledge ecosystems.
e) The importance of ensuring the robustness of the
research before attempting to achieve impact by
implementing the findings, links to other challenges
and tensions around the balance between use of
local or global research. The website of the EViR
Funders’ Form sets out some principles behind the
four points in the Consensus Statement described
above. The second principle states: “Research should
only be funded if set in the context of one or more
existing systematic reviews of what is already known
or an otherwise robust demonstration of a research
gap” [29]. This, therefore, sets a high premium on
drawing on the global stock of knowledge, where it
is available. The approach described in session 7
with the Innovation Pipeline seems broadly in
keeping with this principle. Generally, however, it is
not always clear that all researchers and
implementation teams give sufficient attention to
the global stock of knowledge before starting
studies, or implementing the findings, respectively.
The aim should be to develop systems that invest in
the capacity to review and draw on the
international literature, as well as in mechanisms to
promote the Implementation to Impact of their own
research where appropriate.
Section three: lessons and further work
The overall lesson from the Summit is that various orga-
nizations in Canada and internationally have made con-
siderable progress on Implementation to Impact, often
as a result of well-planned initiatives. This has particu-
larly been the case when the organizations have been, in
the words of Murphy (7A), “value-hunters” rather than
“fund and forgetters”, adopted a systems approach and
undertaken action in a coherent way across a range of
components of a research system. There are, of course,
many further examples from the wider international
community, than those presented at the Summit. Some
of those were presented at the earlier In the Trenches:
Research Translation for Health Impact International
Symposium at Oxford in 2018 [3, 4], including work
from the Novo Nordisk Foundation in Denmark, which
has produced a series of reports on the wider impact of
the research it funds [36, 37]. Nevertheless, in every sys-
tem there are still many challenges and tensions.
Discussion of further work falls into two categories.
 First, recommendations are made based on lessons
from the Summit as to how R&I funders should best
organize themselves to continue to undertake
activities promoting Implementation to Impact.
 Second, thoughts about how the In the Trenches
team might continue to encourage and support
developments in this field.
How might research and innovation funders best
organize themselves to continue to undertake activities
promoting implementation to impact
Diverse recommendations can be made in relation to as-
pects of individual components of a (health) research
system in order to promote Implementation to Impact.
These components were all covered at the Summit, and
include: engaging stakeholders in agenda-setting and
later stages of R&I; developing appropriate impact as-
sessment approaches; equitably building human capacity
to conduct, absorb and use research and organize re-
search systems, and appropriately drawing on infrastruc-
ture funding and databases; producing valid research
outputs; and implementing evidence in ways that lead to
sustainable impact. The Actionable Insights recorded
in Additional file 3 from each of the sessions cover all
these points to varying degrees, along with additional
ideas such as the importance of an impact culture in en-
hancing the chances of achieving sustainable innovation
and impact.
It seems sensible to make an overall recommendation
that the more that funders and organizations can work
on these issues in a comprehensive and coherent way,
the better the chances of addressing the considerable
challenges and tensions that remain. Furthermore, em-
bedding such research systems into the user system (e.g.
healthcare system) is likely to provide the most product-
ive opportunities for stakeholder engagement and Imple-
mentation to Impact. The most comprehensive approach
described in detail at the Summit was that in Alberta
with the Innovation Pipeline. As noted, Crelinsten, the
moderator of session 7 in which Alberta’s Innovation
Pipeline was presented, observed in his Actionable In-
sights that: “The pipeline is both a reflective tool and a
line of sight that can be used to regularly embed the cre-
ation and use of high quality evidence for impact” (7F).
He then made his recommendation to: “promote the use
of the pipeline concept” (7F).
As we also saw from the Summit presentations, some
funders are already making considerable progress in ap-
plying a systems approach. While the overall progress
made by the NIHR was not specifically considered at the
Summit, analysis of its approach could provide crucial
further evidence for any recommendation to adopt a
comprehensive and coherent approach. Sally Davies ana-
lysed the achievements of the first 10 years of the NIHR
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that she created, and while this was not specifically
about Implementation to Impact, it did illustrate the
NIHR had made progress on many of the components
that constitute an effective research system [38]. There
was also a rather more specific, but briefer, analysis con-
sidering the considerable progress made by the NIHR on
most of the components of the WHO’s research system
framework [10, 39]. These analyses were informed by a
major assessment of the achievements of the NIHR dur-
ing its first 10 years [40].
If the thinking in these proceedings about the com-
ponents that constitute a system was combined with
something along the lines of the AHS Innovation
Pipeline, it might possibly form the basis for a new
framework. This is an idea that could be taken fur-
ther forward.
Future in the trenches resources and events
In the post-Summit evaluation survey several respon-
dents expressed an interest in more practical informa-
tion on implementing the ideas presented at the
Summit. One response is that some practical guides rele-
vant to points made in the Summit have been outlined
here in the proceedings and added to the Resources sec-
tion of the Summit website, even in some cases when
they were not specifically referenced in the presenta-
tions. Examples of such material, presented in the order
of the research systems framework, include:
 Ways to engage stakeholders in research, including
in agenda-setting [14, 15, 41]
 Ethical considerations for patient and public
involvement [17]
 Ways to assess research impact and apply research
impact frameworks [1, 20–23]
 Building capacity [24, 25, 42–47]
 Producing valid research outputs [29]
 Implementation to Impact (Fig. 2) [16]
 Continuously improving the (health) research
system [30, 33].
The International School for Research Impact Assess-
ment (ISRIA) continues to demonstrate its value as it
becomes an increasingly important source for analysts
exploring practical ways in which organizations imple-
ment impact assessment [22]. Therefore, a further re-
sponse to the interest expressed in the Summit
evaluation for more information has been to consider
the possibility of building on the experience of the ISRIA
to run international short courses on Implementation to
Impact. Any updates on this idea will be circulated to in-
terested parties and disseminated via the Summit
website.
Conclusions
Contributions made at the Summit support the view that
globally there is increased interest in the benefits that
can accrue from adopting a systems approach to (health)
R&I. The overall lesson from the Summit is that various
organizations in Canada and internationally have made
considerable progress on Implementation to Impact,
often a result of well-planned initiatives. Two of the key
learnings to emerge at the Summit partly highlight the
value of the efforts devoted to creating an engagement
platform for diverse stakeholders to share emerging
knowledge and practical experiences: 1) collaboration
between researchers and potential users, and 2) the
adoption by funders of approaches involving an increas-
ing range of responsibilities and activities. These were all
intended to increase successful implementation and
achievement of impact. The post-Summit evaluation
survey results reinforced delegates’ interest for more
practical information on implementing some of the ideas
presented at the Summit. The Summit website (https://
inthetrenchessummit.com/) will be periodically updated
with new resources and information about future In the
Trenches events.
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